196 related articles for article (PubMed ID: 32792359)
1. Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier.
Lu Z; Chen H; Jiao X; Zhou W; Han W; Li S; Liu C; Gong J; Li J; Zhang X; Wang X; Peng Z; Qi C; Wang Z; Li Y; Li J; Li Y; Brock M; Zhang H; Shen L
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32792359
[TBL] [Abstract][Full Text] [Related]
2. Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer.
Lu Z; Chen H; Li S; Gong J; Li J; Zou J; Wu L; Yu J; Han W; Sun H; Jiao X; Zhang X; Peng Z; Lu M; Wang Z; Zhang H; Shen L
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32792358
[TBL] [Abstract][Full Text] [Related]
3. Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients.
Seitz RS; Hurwitz ME; Nielsen TJ; Bailey DB; Varga MG; Ring BZ; Metts CF; Schweitzer BL; McGregor K; Ross DT
J Transl Med; 2022 Aug; 20(1):370. PubMed ID: 35974414
[TBL] [Abstract][Full Text] [Related]
4. DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
Yan J; Wang S; Zhang J; Yuan Q; Gao X; Zhang N; Pan Y; Zhang H; Liu K; Yu J; Lu L; Liu H; Gao X; Zhao S; Zhang W; Reyila A; Qi Y; Zhang Q; Cang S; Lu Y; Pan Y; Kong Y; Nie Y
Cancer Biol Med; 2023 Dec; 21(3):252-66. PubMed ID: 38164720
[TBL] [Abstract][Full Text] [Related]
5. Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer.
Han Z; Zhang Z; Yang X; Li Z; Sang S; Islam MT; Guo AA; Li Z; Wang X; Wang J; Zhang T; Sun Z; Yu L; Wang W; Xiong W; Li G; Jiang Y
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38749538
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
Chen S; Zhang N; Wang T; Zhang E; Wang X; Zheng J
Front Immunol; 2020; 11():1900. PubMed ID: 32983112
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Efficacy in the Initial Lines of Treatment in Advanced Upper Gastrointestinal Malignancies: A Systematic Review of the Literature.
Kamposioras K; Ntellas P; Nikolaou M; Germetaki T; Gazouli I; Dadouli K; Zarkavelis G; Amylidi AL; Tolia M; Mauri D
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34926989
[TBL] [Abstract][Full Text] [Related]
8. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
9. Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer.
Lu Z; Chen H; Jiao X; Wang Y; Wu L; Sun H; Li S; Gong J; Li J; Zou J; Yang K; Hu Y; Mao B; Zhang L; Zhang X; Peng Z; Lu M; Wang Z; Zhang H; Shen L
Genome Med; 2021 Nov; 13(1):175. PubMed ID: 34732240
[TBL] [Abstract][Full Text] [Related]
10. A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.
Ligero M; Garcia-Ruiz A; Viaplana C; Villacampa G; Raciti MV; Landa J; Matos I; Martin-Liberal J; Ochoa-de-Olza M; Hierro C; Mateo J; Gonzalez M; Morales-Barrera R; Suarez C; Rodon J; Elez E; Braña I; Muñoz-Couselo E; Oaknin A; Fasani R; Nuciforo P; Gil D; Rubio-Perez C; Seoane J; Felip E; Escobar M; Tabernero J; Carles J; Dienstmann R; Garralda E; Perez-Lopez R
Radiology; 2021 Apr; 299(1):109-119. PubMed ID: 33497314
[TBL] [Abstract][Full Text] [Related]
11. Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors.
Wei C; Wang M; Gao Q; Yuan S; Deng W; Bie L; Ma Y; Zhang C; Li S; Luo S; Li N
Cancer Immunol Immunother; 2023 Jan; 72(1):23-37. PubMed ID: 35661905
[TBL] [Abstract][Full Text] [Related]
12. Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.
Zhao C; Wu L; Liang D; Chen H; Ji S; Zhang G; Yang K; Hu Y; Mao B; Liu T; Yu Y; Zhang H; Xu J
Cancer Immunol Immunother; 2021 Sep; 70(9):2669-2679. PubMed ID: 33624146
[TBL] [Abstract][Full Text] [Related]
13. PTCH1 mutation as a potential predictive biomarker for immune checkpoint inhibitors in gastrointestinal cancer.
Deng S; Gu H; Chen Z; Liu Y; Zhang Q; Chen D; Yi S
Carcinogenesis; 2024 May; 45(5):351-357. PubMed ID: 38310539
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
Jiang J; Ding Y; Wu M; Chen Y; Lyu X; Lu J; Wang H; Teng L
Cancer Med; 2020 Nov; 9(22):8498-8518. PubMed ID: 32969604
[TBL] [Abstract][Full Text] [Related]
15. Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer.
Wang Y; Jiao X; Li S; Chen H; Wei X; Liu C; Gong J; Zhang X; Wang X; Peng Z; Qi C; Wang Z; Wang Y; Zhuo N; Zou J; Zhang H; Li J; Shen L; Lu Z
Cancer Biol Med; 2021 Sep; 19(8):1139-49. PubMed ID: 34570439
[TBL] [Abstract][Full Text] [Related]
16. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.
Zeng D; Wu J; Luo H; Li Y; Xiao J; Peng J; Ye Z; Zhou R; Yu Y; Wang G; Huang N; Wu J; Rong X; Sun L; Sun H; Qiu W; Xue Y; Bin J; Liao Y; Li N; Shi M; Kim KM; Liao W
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376552
[TBL] [Abstract][Full Text] [Related]
18. Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment.
Wang Z; Zhao X; Gao C; Gong J; Wang X; Gao J; Li Z; Wang J; Yang B; Wang L; Zhang B; Zhou Y; Wang D; Li X; Bai Y; Li J; Shen L
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33172882
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
20. An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma.
Pan C; Tang H; Wang W; Wu D; Luo H; Xu L; Lin XJ
Front Oncol; 2022; 12():1077477. PubMed ID: 36733353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
